Glavas N A, Ostenson C, Schaefer J B, Vasta V, Beavo J A
Department of Pharmacology, Box 357280, University of Washington, Seattle, WA 98195, USA.
Proc Natl Acad Sci U S A. 2001 May 22;98(11):6319-24. doi: 10.1073/pnas.101131098.
Agents that increase intracellular cAMP inhibit the activation and function of T cells and can lead to cell death. Recently, it has been postulated that cAMP inhibits T cell function in large part by acting as a brake on the T cell receptor and costimulatory receptor pathways. Therefore, for full activation of the T cell to occur, this inhibitory influence must be removed. One likely mechanism for accomplishing this is by up-regulation and/or activation of specific cyclic nucleotide phosphodiesterases (PDEs), and such a mechanism for one phosphodiesterase, PDE7A1, has been reported. In this paper, we extend this mechanism to another isozyme variant of the same PDE family, PDE7A3. We also report the full-length sequence of human PDE8A1 and show that it also is induced in response to a combination of T cell receptor and costimulatory receptor pathway activation. However, the time course for induction of PDE8A1 is slower than that of PDE7A1. The basal level measured and, therefore, the apparent fold induction of PDE7A1 mRNA and protein depend in large part on the method of isolation of the T cells. On the other hand, regardless of the isolation method, the basal levels of PDE7A3 and PDE8A1 are very low and fold activation is much higher. Constitutively expressed PDE8A1 and PDE7A3 also have been isolated from a human T cell line, Hut78.
增加细胞内cAMP的因子会抑制T细胞的激活和功能,并可导致细胞死亡。最近,有人提出cAMP在很大程度上通过对T细胞受体和共刺激受体途径起到制动作用来抑制T细胞功能。因此,为使T细胞完全激活,必须消除这种抑制性影响。实现这一点的一种可能机制是通过上调和/或激活特定的环核苷酸磷酸二酯酶(PDE),并且已经报道了一种磷酸二酯酶PDE7A1的这种机制。在本文中,我们将这种机制扩展到同一PDE家族的另一种同工酶变体PDE7A3。我们还报告了人PDE8A1的全长序列,并表明它也在T细胞受体和共刺激受体途径激活的联合作用下被诱导。然而,PDE8A1的诱导时间进程比PDE7A1慢。所测量的基础水平以及因此PDE7A1 mRNA和蛋白质的表观诱导倍数在很大程度上取决于T细胞的分离方法。另一方面,无论分离方法如何,PDE7A3和PDE8A1的基础水平都非常低,激活倍数则高得多。组成型表达的PDE8A1和PDE7A3也已从人T细胞系Hut78中分离出来。